All Square Wealth Management LLC Nektar Therapeutics Transaction History
All Square Wealth Management LLC
- $174 Million
- Q3 2024
A detailed history of All Square Wealth Management LLC transactions in Nektar Therapeutics stock. As of the latest transaction made, All Square Wealth Management LLC holds 277 shares of NKTR stock, worth $260. This represents 0.0% of its overall portfolio holdings.
Number of Shares
277
Previous 277
-0.0%
Holding current value
$260
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding NKTR
# of Institutions
145Shares Held
139MCall Options Held
32.6KPut Options Held
14.1K-
Deep Track Capital, LP Greenwich, CT15.9MShares$15 Million0.76% of portfolio
-
Black Rock Inc. New York, NY15.2MShares$14.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$12.3 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA9.4MShares$8.84 Million0.22% of portfolio
-
Samlyn Capital, LLC New York, NY9.2MShares$8.65 Million0.19% of portfolio
About NEKTAR THERAPEUTICS
- Ticker NKTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,404,992
- Market Cap $176M
- Description
- Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...